LEADER 02214 am  2200529 n 450 
001 9910313025503321
005 20180216
010   $a2-35596-027-5
024 7 $a10.4000/books.irasec.1192
035   $a(CKB)4960000000012693
035   $a(FrMaCLE)OB-irasec-1192
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/59978
035   $a(PPN)229999832
035   $a(EXLCZ)994960000000012693
100   $a20180703j||||||||  |||            0
101 0 $aeng
135   $auu||||||m||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe State of Medicine Quality in the Mekong Sub-Region /$fSauwakon Ratanawijitrasin, Souly Phanouvong
210   $aBangkok $cInstitut de recherche sur l?Asie du Sud-Est contemporaine$d2018
215   $a1 online resource (88 p.) 
311   $a616-7571-19-8 
330   $aThis study aims to increase awareness and interest on the pharmaceutical quality and counterfeit medicines issues in the Mekong Subregion.  It provides a review of existing empirical findings regarding the state of medicine quality in the region. It also analyzes data on quality testing of drug samples from the five countries (Cambodia, China, Lao PDR, Thailand and Vietnam) in the region, in order to develop a conceptual framework for addressing the issue at the regional level, and to suggest areas for further study.
606   $aDrugs$xQuality control
606   $aMedicine$xQuality control
607   $aMekong River Region$xSocial conditions
607   $aSoutheast Asia$xSocial conditions
610   $amedecine quality
610   $adrug regulation
610   $aSoutheast Asia
610   $apharmaceutical policies
610   $aepidemics
610   $acounterfeit
610   $aMekong Subregion
610   $ahealth
615  0$aDrugs$xQuality control.
615  0$aMedicine$xQuality control.
700   $aRatanawijitrasin$b Sauwakon$01157627
701   $aPhanouvong$b Souly$01322675
712 02$aIRASEC,
801  0$bFR-FrMaCLE
906   $aBOOK
912   $a9910313025503321
996   $aThe State of Medicine Quality in the Mekong Sub-Region$93035144
997   $aUNINA